WO2014095891A1 - Procédé de détection de trichophytons et de pathologies associée - Google Patents
Procédé de détection de trichophytons et de pathologies associée Download PDFInfo
- Publication number
- WO2014095891A1 WO2014095891A1 PCT/EP2013/076939 EP2013076939W WO2014095891A1 WO 2014095891 A1 WO2014095891 A1 WO 2014095891A1 EP 2013076939 W EP2013076939 W EP 2013076939W WO 2014095891 A1 WO2014095891 A1 WO 2014095891A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease
- subtilisin
- seq
- trichophyton
- leucine aminopeptidase
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/958—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from fungi
Definitions
- the present invention relates to the detection of the presence of fungi of the genus Trichophyton in humans or animals, in the skin and superficial body growths.
- the invention relates to a method for detecting trichophytons, comprising a step of determining the presence in a sample of skin or integument of at least one protease selected from five particular proteases.
- the subject of the invention is also specific monoclonal antibodies directed against these proteases and a diagnostic kit containing them.
- Trichophytons are parasitic fungi that develop on the skin, scalp or nails and cause dermatophytosis in humans or animals. In humans, for example, trichophytons may be responsible for cir - cular herpes on the skin, ringworm on the scalp, kerion or trichophytic sycosis on the beard and onychomycosis on the nails.
- fungal infections of the skin or superficial body growths may be due to fungal agents other than trichophyton, such as yeasts, molds or other dermatophytes, and in this case the treatment must be different.
- fungal agents other than trichophyton such as yeasts, molds or other dermatophytes
- the treatment must be different.
- they can be confused with other pathologies or traumatisms of the skin or integuments.
- clinical signs of nail dystrophy such as Psoriasis, trauma, nail tumor, lichen planus and bacterial infection resemble onychomycosis and can be confusing.
- the invention therefore relates to the use of at least one protease selected from dipeptidyl peptidase V, subtilisin - like protease 6, subtilisin - like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2, for the detection of the presence, in a sample of skin or human or animal dander, of at least one trichophyton.
- the invention provides a method for detecting the presence of at least one trichophyton, comprising a step of determining the presence in a sample of skin or dander derived from a human being or an animal susceptible of to be infected with a trichophyton, of at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2.
- Trichophyton sought and detected are involved in pathologies of the skin and / or superficial body growths.
- dander in the sense of the invention is meant any protective epidermal productions, annexes or integuments, containing a high percentage of keratin such as hair, hair and nails.
- the presence of at least one of these proteases at the level of the skin or integuments is specific only to the presence of trichophytons.
- This determination can be made by a variety of means that can be used for rapid, easy to use, and trichophyton - specific diagnostic tools, thus enabling effective and targeted treatment to be implemented in a very short time. Two means are particularly suitable, determination by mass spectrometry and immuno-detection.
- the invention also relates to a monoclonal antibody directed against dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2 or a fragment of this antibody capable of binding respectively to dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2, and a kit comprising such an antibody.
- Figure 1 describes the limit of quantification of dipeptidyl peptidase V.
- the invention thus relates to the use of at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2, for the detection of the presence, in a sample of skin or human or animal dander, of at least one trichophyton involved in a mycoin of the skin and / or superficial body growths.
- protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2
- this use consists of the implementation of a method for detecting the presence of at least one trichophyton involved in a mycoin of the skin and / or superficial body growths, comprising a step of determining the presence in a sample of skin or integument derived from a human being or from an animal likely to be infected by a trichophyton, at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7 , leucine aminopeptidase 1 and leucine aminopeptidase 2.
- the determination of the presence of at least one of the proteases is carried out in vitro from a sample of skin or integuments, but reflects the presence of this protease in vivo at the level of the skin or integuments of the person where the animal from which the sample was taken.
- the samples used for the implementation of the invention are obtained by any suitable means.
- the sample is a nail sample, it is preferably obtained by scraping the nail bed or by piercing the nail with a micro chigno. This latter method of sampling is described in US Pat. No. 7,848,799.
- the sample comes from a mycotic lesion of the skin, it is preferably obtained by scraping with the aid of a curette.
- the presence in the sample of at least one protease selected from dipeptidyl peptidase V, subtilisin - like protease 6, subtilisin - like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2 is synonymous infection with at least one trichophyton.
- proteases secreted specifically by trichophytons playing a role in the digestion of keratins and which, according to the invention, are found in the skin and integuments infected by at least one trichophyton.
- the use according to the invention is suitable for the detection of any trichophyton involved in a mycosis of the skin and / or superficial body growths in humans or animals, in particular Trichophyton bullosum, Trichophyton circonvolutum, Trichophyton concentricum, Trichophyton eboreum, Trichophyton equinum, Trichophyton eriotrephon, Trichophyton fischeri, Trichophyton gourvilii, Trichophyton interdigital, Trichophyton Kanei, Trichophyton krajdenii, Trichophyton longifusum, Trichophyton megninii, Trichophyton mentagrophytes, Trichophyton phaseoliforme, Trichophyton quinckeanum, Trichophyton raubitschekii, Trichophyton rubrum, Trichophyton schoenleinii, Trichophyton soudanense, Trichophyton sp .
- Trichophyton sp. FSU 10097 Trichophyton sp. IFM 411 72, Trichophyton sp. LM 10725, terrestrial Trichophyton, Trichophyton thuringiense, Trichophyton tonsurans, Trichophyton vanbreuseghemii, Trichophyton verrucosum, Trichophyton violaceum and Trichophyton yaoundei, regardless of the strain if there are several.
- the use according to the invention is particularly suitable for the detection of interdigital Trichophyton and / or Trichophyton rubrum, even more preferably of Trichophyton rubrum, whatever the strain.
- the detection of the presence of trichophytons by the determination of at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2 according to the invention can in particular be used for the screening, the therapeutic monitoring and / or the diagnosis of a pathology in humans or animals, in particular of a myco linked to a trichophyton infection.
- the invention also relates to at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2, for use in a screening method. , for therapeutic monitoring and / or diagnosis of a pathology related to infection with at least one trichophyton,
- the invention is particularly directed to the detection, therapeutic monitoring and / or diagnosis of onychomycosis.
- the invention also targets at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2, for use in a screening method. , therapeutic monitoring and / or diagnosis of onychomycosis.
- therapeutic monitoring is meant the use according to the invention and more particularly the method for detecting the presence of trichophytons in a sample of skin or appendages of a human being or an animal to follow the evolution of treatment of trichophyton infection.
- the use according to the invention and more particularly the method for detecting the presence of trichophytons in a sample of skin or appendages of a human being or of an animal comprises a step of determining the the presence of at least one protease selected from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 and leucine aminopeptidase 2, by quantitative mass spectrometry (MRM - "Multip Reaction") Monitoring) ".
- MRM quantitative mass spectrometry
- the MRM method allows the detection and the quantification of a given protein in a complex mixture, using a mass spectrometer which makes it possible to target the peptides of a given protein and to detect only these for the quantify.
- the mass spectrometry analyzes are preferably carried out with different mass spectra essentially in MS / MS mode coupled upstream to nano-HPLC.
- the peptide assay can also be performed with a different (ionizing) source of the MALDI type. According to the invention, this step consists in particular of identifying by quantitative mass spectrometry at least one of the peptide sequences belonging to one of said proteases, preferably one of the following peptide sequences:
- Sequences 1 to 5 are specific for dipeptidyl peptidase V
- sequence 6 is specific for leucine aminopeptidase 2
- sequences 7 to 9 are specific for leucine aminopeptidase 1
- sequences 10 to 14 are specific for subtilisin-like protease 6 and the sequence is specific for the subtilisin-like protease 7.
- the detection of at least one of the peptide sequences belonging to dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 or leucine aminopeptidase 2 is specific for the presence of a trichophyton. in the sample and therefore a pathology related to the presence of this trichophyton.
- This method makes it possible to detect the trichophytons present with high sensitivity, high specificity, and high selectivity. According to another advantage, it also makes it possible to quantify the proteases detected and therefore to quantify the trichophytons present in the sample.
- the use according to the invention and more particularly the method for detecting the presence of trichophytons in a sample of skin or appendages of a human being or an animal comprises the use of an immunoassay for determining the presence in the sample of at least one of the proteases chosen from dipeptidyl peptidase V, subtilisin-like protease 6, subtilisin-like protease 7, leucine aminopeptidase 1 or leucine aminopeptidase 2, preferably at least one of the proteases chosen from dipeptidyl peptidase V, subtilisin-like protease 6 and leucine aminopeptidase 2.
- this immunological test comprises the use of at least one monoclonal antibody directed against dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2 or a fragment of this antibody capable of binding respectively to the dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2.
- This antibody can especially be used to detect and identify the presence of dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2 by an immuno-detection system such as, for example, a liquid-phase immuno-detection (ELISA for example ) or in the semi-solid phase or a method based on a lateral flow system ("lateral flow system").
- an immuno-detection system such as, for example, a liquid-phase immuno-detection (ELISA for example ) or in the semi-solid phase or a method based on a lateral flow system ("lateral flow system").
- ELISA liquid-phase immuno-detection
- lateral flow system Similar systems are already known, for example, for the rapid diagnosis of Group A streptococcal streptococci (Streptatest).
- this method makes it possible to detect the presence of trichophytons with high sensitivity and high specificity.
- this process can be implemented by all and allows to get a result quickly, usually in 15 minutes.
- the invention also relates to monoclonal antibodies directed against dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2 or a fragment of these antibodies capable of binding dipeptidyl, respectively.
- These antibodies are obtained by conventional methods from rodent inoculation, for example, dipeptidyl peptidase V, subtilisin-like protease 6 or leucine. aminopeptidase 2.
- the proteins or fragments of these purified or recombinant proteins obtained by genetic engineering are used as immunogens.
- the invention provides a diagnostic kit for a pathology of the skin and / or integuments related to infection with at least one trichophyton, comprising at least one monoclonal antibody directed against dipeptidyl peptidase V, subtilisin -like protease 6 or leucine aminopeptidase 2 or fragment of this antibody capable of binding respectively to dipeptidyl peptidase V, subtilisin-like protease 6 or leucine aminopeptidase 2.
- it is a kit for the rapid diagnosis of onychomycosis.
- the invention is now exemplified by nonlimiting tests, illustrating the invention and showing in particular its high specificity with regard to the detection of the presence of trichophytons in infected subjects. Some tests were performed by mass spectrometry and others by immuno - detection from nail or skin samples.
- the samples obtained from human nails are obtained by scraping the nail bed of patients suffering from onychomycosis or other onychopathies.
- the proteins were extracted and solubilized in a solution containing 50 mM ammonium bicarbonate and 0.1% nonionic detergent ALS-400 (ref Proteabio) which is compatible with mass spectrometry analysis. .
- the extraction was carried out with stirring in a Thermo mixer (Eppendorf) at a speed of 1400 rpm and at 4 ° C for 2 hours.
- the supernatant containing the solubilized proteins was recovered by centrifugation (at 14000 rpm, at 4 ° C, for 10 minutes).
- the insoluble debris was removed by filtration through a 0.22 ⁇ filter (Millipore, Billerica, U.S. UFC30GVNB) by centrifugation at 14000 rpm at 4 ° C for 10 minutes.
- the western blot analyzes are carried out after the separation of the proteins in SDS-PAGE, according to the following protocol:
- the membrane is scanned for detection in the infrared (Odyssey LI-COR, Germany).
- the mass spectrometry analyzes were carried out with a triple quad, QSTAR® XL (APPLIED BIO SYSTEMS), essentially in MS / MS mode coupled upstream to nano-HPLC.
- Sample preparation for mass spectrometric analysis includes a step of reducing and alkylating protein disulfide bridges, followed by an enzymatic digestion step (trypsin is currently the most commonly used). The peptides obtained by digestion are then analyzed by mass spectrometry.
- Enzymatic digestion can be done either directly in the gel: “in-gel” digestion or in solution.
- “gel” digestion the proteins are separated beforehand in SDS-PAGE.
- the digestion in solution makes it possible to digest all the proteins from the same protein fraction. This method is generally used in cases where the samples are weakly complex or are not compatible with SDS-PAGE separation.
- the combination of SDS-PAGE and in-gel digestion shows the advantage of denaturing and separating proteins and thus limiting the influence of very abundant proteins which, by steric hindrance, hinder analysis by mass spectrometry.
- Trypsin was used to "cut" the protein (s) into peptides which will then be analyzed by mass spectrometry.
- Trypsin specifically hydrolyzes the peptide bond on the C-terminal side after the amino acids lysine and arginine (Lys-Xaa or Arg-Xaa) if the next amino acid is not a proline.
- the amount of trypsin was used in ratios (enzyme / substrate) of between 1: 1 and 1: 100 in order to avoid autolysis of trypsin in the case of a too high concentration of enzyme or incomplete hydrolysis. proteins in the case of trypsin concentration too low.
- the digestion in solution with trypsin was carried out in an enzyme / protein ratio of between 1/100 and 1/10 from a solution of trypsin (1 mg / ml) previously diluted in a 1 mM HC1 solution. . Incubation was performed at 37 ° C overnight with shaking.
- the gel pieces were covered with 200 ⁇ l of 120 mM ammonium bicarbonate with 40% acetonitrile (ACN) and incubated at 37 ° C for 30 minutes. The solutions have been eliminated.
- ACN acetonitrile
- the HPLC system (LC Packing / DIONEX) is composed of an Ultimate pump with a divider allowing to deliver a nano flow (of the order of 200 nanoL / min.), A sample injector Famo s (also configurable in 96 well plate) and a Switchos pump allowing a pre - concentration of the samples as well as the elimination of the salts which can hinder the detection by mass spectrometry.
- the mobile phase is composed of a phase A (95 vo lumes of water, 5 volumes of ACN and 0. 1 volume of formic acid) and a phase B (95 vo lumes of ACN, 5 vo lumes of water and 0. 1 volume of formic acid) with a flow rate of 200 nL / min following a gradient for the separation of the peptides.
- the chromatographic separation is carried out on an Atlantis C 18 column, Waters (75 ⁇ x 15 cm) with a particle size of 3 ⁇ .
- Pre-concentration of the sample is carried out on a C 1 8 LcPaking column 5 mm long, 300 ⁇ in diameter and with a particle size of 5 ⁇ .
- the pre-concentration mobile phase is composed of a phase C (97 vol water, 3 volumes of ACN and 0. 1 volume of formic acid) with a flow rate of 30 ⁇ / ⁇ .
- the valve is tilted 3 minutes after the injection.
- the injection volume is ⁇ ⁇ , but can be, depending on the type of analysis, increased to 10 ⁇ ,.
- the mass spectrometer is composed of a nano electrospray source (nanoESI), whose needle voltage is between 1000 and 2000 V set during calibration.
- the resolution is between 1 1000 and 13000 at mass 879.9 amu (atomic mass unit) (during calibration), the level of curtain gas (curtain gas) is 30. All spectra have been acquired in ion reflector mode positive.
- the quadrupole analyzer was used to fragment the argllion cell with argon. Fragmentation is performed for ions larger than 400 amu and smaller than 1200 amu with a state of charge between 2 and 3 amu and whose abundance is greater than 10 counts. These ions are excluded for 20 seconds after acquisition and for a window of 4.0 amu, the number of scans acquired for each MS / MS is 1 or 2. The duration of the runs varies from 80 minutes to 90 minutes depending on the samples and controls Quality is performed approximately every 10 runs by injections of digest of glutamate dehydrogenase at a concentration of 50 femtomo. If the glutamate dehydrogenase digest is identified on more than 5 significant peptides using the Mascot software, the analyzes are considered valid.
- proteases sought are:
- DDPIV dipeptidyl peptidase IV
- DDPV dipeptidyl peptidase V
- subtilisin-like protease 4 (SUB4)
- subtilisin-like protease 6 (SUB6)
- subtilisin-like protease 7 (SUB7)
- LAP2 leucine aminopeptidase 2
- proteases are not present in traumatized nails, not infected with a trichophyton.
- proteases sought are:
- DDPIV dipeptidyl peptidase IV
- DDPV dipeptidyl peptidase V
- subtilisin-like protease 4 (SUB4)
- subtilisin-like protease 6 (SUB6)
- subtilisin-like protease 7 (SUB7)
- LAP 1 leucine aminopeptidase 1
- LAP2 leucine aminopeptidase 2
- M14A metallocarboxypeptidase
- the dipeptidyl peptidase V specific for Trichophyton rubrum (Uniprot code of the sequence: Q9UW98) was obtained in the form of a recombinant protein and then purified.
- the clones were selected according to the protocol of the kit
- Antibody pair buffer kit (InVitrogen, ref CNB0011):
- MAXISORP plates are incubated with DPPV at a concentration of 2 ⁇ g / mL diluted in ASSAY BUFFER, deposition of 50 ⁇ l per well 3 h at 37 ° C. with shaking at 300 rpm.
- Peroxidase (rabbit anti-mouse) diluted with ASSAY BUFFER at 100 ⁇ / well, and incubate for 30 min at room temperature with shaking at 300 rpm.
- Dipeptidyl peptidase V was used at the concentration of 2 ⁇ / ⁇ ⁇ .
- the positive control consists of the serum that was used to immunize mice to obtain clones (at a dilution of 1/1000 in saturation buffer).
- White corresponds to the condition without clones.
- MAXISORP plates are incubated with the capture antibody (non-biotinylated) in PBS at a concentration of 2 ⁇ g / mL overnight at 4 ° C and 37 ° C. Saturation of the plate with 150 ⁇ . of ASSAY BUFFER, then incubation for 3h at 37 ° C with shaking at 300 rpm
- the first "capture” antibody is absorbed on the bottom of the 96-well plate (Greiner) at the concentration of 2 ⁇ g / ml.
- the DPPV protein is used at a concentration of 0.2 ⁇ g / ml.
- the second antibody coupled to biotin (revealing antibody) is used at the concentration of 0.01 g / ml.
- the pair of antibodies comprising as capture antibody clone 8H4B11B12C10 and as detection antibody clone 6C4B12F12D9 is the most promising for the realization of the sandwich ELISA and was retained.
- Dipeptidyl peptidase V was assayed from various biological samples from nail infected with Trichophyton rubrum, but also from nail infected with other pathogens. In addition, nail samples showing negative mycology (psoriasis, trauma), as well as healthy skin were also used Protein extraction was performed as previously described.
- the detection of DPPV in the biological samples was performed as described for the standard range (using the DPPV purified recombinant protein).
- the total protein concentration in the biological samples was determined by the Bradford method.
- the concentration of DPPV obtained by assay and expressed in ⁇ g / mL was normalized with respect to the total protein concentration determined by the Bradford method and expressed in ⁇ g of DPPV / mg of total protein.
- the data show the good sensitivity of the ELISA test and a high specificity (only samples containing Trichophyton are positive in ELISA).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112015014810A BR112015014810A2 (pt) | 2012-12-21 | 2013-12-17 | processo de detecção da presença de pelo menos um tricofiton, anticorpo monoclonal, kit e pelo menos uma protease |
US14/654,229 US20160054319A1 (en) | 2012-12-21 | 2013-12-17 | Method for detecting trichophytons and associated diseases |
RU2015129754A RU2015129754A (ru) | 2012-12-21 | 2013-12-17 | Способ детекции трихофитонов и связанных с ними патологий |
JP2015548451A JP2016511390A (ja) | 2012-12-21 | 2013-12-17 | トリコフィトン(Trichophyton)属菌及び関連する疾患を検出するための方法 |
KR1020157019696A KR20150096793A (ko) | 2012-12-21 | 2013-12-17 | 백선균 및 관련 질환의 검출 방법 |
MX2015007914A MX2015007914A (es) | 2012-12-21 | 2013-12-17 | Proceso de deteccion de tricofitones y de las patologias asociadas. |
CA2908752A CA2908752A1 (fr) | 2012-12-21 | 2013-12-17 | Procede de detection de trichophytons et de pathologies associees |
AU2013361716A AU2013361716A1 (en) | 2012-12-21 | 2013-12-17 | Method for detecting trichophytons and associated diseases |
CN201380073640.9A CN105008927A (zh) | 2012-12-21 | 2013-12-17 | 用于检测毛癣菌属与相关疾病的方法 |
EP13814089.2A EP2936156A1 (fr) | 2012-12-21 | 2013-12-17 | Procédé de détection de trichophytons et de pathologies associée |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1262652 | 2012-12-21 | ||
FR1262652A FR3000216B1 (fr) | 2012-12-21 | 2012-12-21 | Utilisation de proteases particulieres pour la detection de trichophytons et de pathologies associees |
US201261745912P | 2012-12-26 | 2012-12-26 | |
US61/745912 | 2012-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014095891A1 true WO2014095891A1 (fr) | 2014-06-26 |
Family
ID=48521055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/076939 WO2014095891A1 (fr) | 2012-12-21 | 2013-12-17 | Procédé de détection de trichophytons et de pathologies associée |
Country Status (12)
Country | Link |
---|---|
US (1) | US20160054319A1 (fr) |
EP (1) | EP2936156A1 (fr) |
JP (1) | JP2016511390A (fr) |
KR (1) | KR20150096793A (fr) |
CN (1) | CN105008927A (fr) |
AU (1) | AU2013361716A1 (fr) |
BR (1) | BR112015014810A2 (fr) |
CA (1) | CA2908752A1 (fr) |
FR (1) | FR3000216B1 (fr) |
MX (1) | MX2015007914A (fr) |
RU (1) | RU2015129754A (fr) |
WO (1) | WO2014095891A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2009111A1 (fr) * | 2006-03-20 | 2008-12-31 | National University Corporation University of Fukui | Méthode de détection de dermatophyte sans chauffage |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU22584A1 (es) * | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
US7468267B2 (en) * | 2003-08-25 | 2008-12-23 | Funzyme Biotechnologies Sa | Fungal proteins and nucleic acids encoding same |
US7906276B2 (en) * | 2004-06-30 | 2011-03-15 | Kimberly-Clark Worldwide, Inc. | Enzymatic detection techniques |
JP2007236338A (ja) * | 2006-03-10 | 2007-09-20 | Canon Inc | トリコフィトン(Trichophyton)属菌を検出するための核酸断片及びそれを用いたトリコフィトン(Trichophyton)属菌の検出方法 |
JP5750216B2 (ja) * | 2009-04-17 | 2015-07-15 | 株式会社カネカ | 新規リンカーを用いた抗菌剤および診断薬 |
-
2012
- 2012-12-21 FR FR1262652A patent/FR3000216B1/fr not_active Expired - Fee Related
-
2013
- 2013-12-17 MX MX2015007914A patent/MX2015007914A/es unknown
- 2013-12-17 KR KR1020157019696A patent/KR20150096793A/ko not_active Application Discontinuation
- 2013-12-17 AU AU2013361716A patent/AU2013361716A1/en not_active Abandoned
- 2013-12-17 RU RU2015129754A patent/RU2015129754A/ru not_active Application Discontinuation
- 2013-12-17 CN CN201380073640.9A patent/CN105008927A/zh active Pending
- 2013-12-17 JP JP2015548451A patent/JP2016511390A/ja active Pending
- 2013-12-17 CA CA2908752A patent/CA2908752A1/fr not_active Abandoned
- 2013-12-17 BR BR112015014810A patent/BR112015014810A2/pt not_active IP Right Cessation
- 2013-12-17 EP EP13814089.2A patent/EP2936156A1/fr not_active Withdrawn
- 2013-12-17 WO PCT/EP2013/076939 patent/WO2014095891A1/fr active Application Filing
- 2013-12-17 US US14/654,229 patent/US20160054319A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2009111A1 (fr) * | 2006-03-20 | 2008-12-31 | National University Corporation University of Fukui | Méthode de détection de dermatophyte sans chauffage |
Non-Patent Citations (3)
Title |
---|
JOUSSON O ET AL: "Secreted subtilisin gene family in Trichophyton rubrum", GENE, ELSEVIER, AMSTERDAM, NL, vol. 339, 15 September 2004 (2004-09-15), pages 79 - 88, XP004566963, ISSN: 0378-1119, DOI: 10.1016/J.GENE.2004.06.024 * |
MONOD ET AL: "aminopeptidases and dipeptidyl-peptidases secreted by the dermatophyte Trichophyton rubrum", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 151, 1 January 2005 (2005-01-01), pages 145 - 155, XP002321813, ISSN: 1350-0872, DOI: 10.1099/MIC.0.27484-0 * |
ZAUGG C ET AL: "Trichophyton rubrum secreted and membrane-associated carboxypeptidases", INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, URBAN UND FISCHER, DE, vol. 298, no. 7-8, 1 October 2008 (2008-10-01), pages 669 - 682, XP024341201, ISSN: 1438-4221, [retrieved on 20080128], DOI: 10.1016/J.IJMM.2007.11.005 * |
Also Published As
Publication number | Publication date |
---|---|
RU2015129754A (ru) | 2017-01-25 |
JP2016511390A (ja) | 2016-04-14 |
EP2936156A1 (fr) | 2015-10-28 |
MX2015007914A (es) | 2015-10-05 |
BR112015014810A2 (pt) | 2017-07-11 |
FR3000216A1 (fr) | 2014-06-27 |
AU2013361716A1 (en) | 2015-07-09 |
US20160054319A1 (en) | 2016-02-25 |
FR3000216B1 (fr) | 2015-02-06 |
CN105008927A (zh) | 2015-10-28 |
KR20150096793A (ko) | 2015-08-25 |
CA2908752A1 (fr) | 2014-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2089720B1 (fr) | Utilisation cosmetique d'une proteine de la famille des ribonucleases | |
EP2435835B1 (fr) | Nouveau procede de quantification de proteines par spectrometrie de masse | |
EP2223120A1 (fr) | Méthode non-invasive de recueil de données biologiques pour l'établissement d'un diagnostic d'une pathologie cutanée | |
CA2633912A1 (fr) | Distinction des meningites bacteriennes et virales | |
EP3295178B1 (fr) | Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee | |
WO2004022769A2 (fr) | Moyens de detection des processus neurodegeneratifs et leurs applications | |
WO2014095891A1 (fr) | Procédé de détection de trichophytons et de pathologies associée | |
CA2884356C (fr) | Procede pour le diagnostic de dystrophies musculaires | |
WO2014118474A1 (fr) | Procédé de detection d'un cancer colorectal | |
FR2822955A1 (fr) | Methode de diagnostic de maladies inflammatoires chroniques de l'intestin | |
FR3002044A1 (fr) | Marqueur dyrk1a pour la maladie d'alzheimer | |
WO2005098017A1 (fr) | Procede de production de banques de peptides | |
FR2940977A1 (fr) | Utilisation de formes complexes de la proteine de type calmodulin-like skin protein clsp | |
FR2926369A1 (fr) | Utilisation d'une proteine ou d'une sequence peptidique nitree pour la mise en oeuvre d'une methode de diagnostic | |
FR2792638A1 (fr) | Peptides derives de la vasostatine i et leur utilisation comme antifongiques | |
FR3132644A1 (fr) | Procédé de criblage d’actifs permettant de prévenir la diminution et/ou de renforcer les défenses de la peau comprenant la mesure du niveau d’expression ou d’activité de l’IDE | |
EP0785432A1 (fr) | Procédé pour l'identification ou le dosage immunologique d'antigènes polypeptidiques | |
WO2001023574A1 (fr) | Marqueurs moleculaires du stade de pregermination des semences vegetales et leurs utilisations dans des tests elisa | |
FR3096459A1 (fr) | Procédé de préparation d’un échantillon peptidique | |
FR2757862A1 (fr) | Peptides antigeniques reagissant avec les anticorps anti-ovaire | |
WO2014132204A9 (fr) | Anticorps anti-gluten desamide et utilisations | |
WO2000052475A1 (fr) | Procede d'evaluation de l'intensite de la proteolyse musculaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13814089 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2908752 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013814089 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/007914 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2015548451 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14654229 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015014810 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2013361716 Country of ref document: AU Date of ref document: 20131217 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20157019696 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2015129754 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112015014810 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150619 |